Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07591090 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Phase II Study of AK146D1 Combined With AK112 in Advanced Breast Cancer

Name: A Phase II Study of AK146D1 Combined With AK112 in Advanced Breast Cancer — clinical trial record (NCT07591090)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 2

SponsorAkeso

Started2026-07-17

View on ClinicalTrials.gov ↗

Amendment history

2026-07-21

Study Status, Contacts/Locations v1

Recruitment opened

Start dateestimated 2026-06-01→confirmed 2026-07-17

Study sitesdetails revised at 1 of 1 site

2026-05-09

Original filing

Akeso

96 trials monitored

See 1 trial at risk

Breast Cancer

5,180 trials monitored

See 256 trials at risk

This is a Phase II clinical study aimed at evaluating the safety, tolerability, antitumor efficacy, PK and immunogenicity of AK146D1 combined with AK112 in advanced breast cancer.

Trial Details

NCT Number	NCT07591090
Lead Sponsor	Akeso
Conditions	Advanced Breast Cancer
Enrollment	200 participants
Start Date	2026-07-17
Primary Completion	2027-09-01 (estimated)
Study Completion	2029-02-04 (estimated)
Updated on ClinicalTrials.gov	2026-07-22